Bionano Genomics/$BNGO
1D1W1MYTD1Y5YMAX
Capital at risk
About Bionano Genomics
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
- Ticker
- $BNGO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 96
- Headquarters
- San Diego, United States
- Website
- bionano.com
Bionano Genomics Metrics
BasicAdvanced
$14M
-
-$3.37
1.62
-
Price and volume
Market cap
$14M
Beta
1.62
52-week high
$5.50
52-week low
$1.00
Average daily volume
154K
Financial strength
Current ratio
2.478
Quick ratio
1.423
Long term debt to equity
18.44
Total debt to equity
21.211
Interest coverage (TTM)
-114.16%
Profitability
EBITDA (TTM)
-22.873
Gross margin (TTM)
47.50%
Net profit margin (TTM)
-106.58%
Operating margin (TTM)
-106.68%
Effective tax rate (TTM)
-0.21%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
-32.56%
Return on equity (TTM)
-83.56%
Valuation
Price to revenue (TTM)
0.379
Price to book
0.45
Price to tangible book (TTM)
0.47
Price to free cash flow (TTM)
-0.559
Free cash flow yield (TTM)
-178.86%
Free cash flow per share (TTM)
-2.146
Growth
Revenue change (TTM)
10.03%
Earnings per share change (TTM)
-89.55%
3-year revenue growth (CAGR)
-1.43%
3-year earnings per share growth (CAGR)
-77.40%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.